From: MiRNA155HG polymorphisms influenced the risk of liver cancer among the Han Chinese population
SNP ID | Model | Genotype | Case (number) | Control (number) | Before adjusted | After adjusted | Power | ||
---|---|---|---|---|---|---|---|---|---|
OR (95%CI) | pa | OR (95%CI) | pb | ||||||
rs12482371 | Genotype | TT | 217 | 208 | 1.00 | 1.00 | 68.97% | ||
CT | 185 | 171 | 1.04 (0.78 - 1.38) | 0.801 | 1.04 (0.78 - 1.37) | 0.801 | |||
CC | 30 | 51 | 0.56 (0.35 - 0.92) | 0.022* | 0.56 (0.35 - 0.92) | 0.022* | |||
Dominant | TT | 217 | 208 | 1.00 | 1.00 | ||||
CT-CC | 215 | 222 | 0.93 (0.71 - 1.21) | 0.585 | 0.93 (0.71 - 1.21) | 0.586 | |||
Recessive | TT-CT | 402 | 379 | 1.00 | 1.00 | ||||
CC | 30 | 51 | 0.55 (0.35 - 0.89) | 0.014* | 0.55 (0.35 - 0.89) | 0.015* | |||
Log-additive | – | – | – | 0.85 (0.70 - 1.05) | 0.129 | 0.85 (0.70 - 1.05) | 0.129 | ||
rs1893650 | Genotype | TT | 281 | 279 | 1.00 | 1.00 | 63.95% | ||
CT | 145 | 135 | 1.07 (0.80 - 1.42) | 0.661 | 1.07 (0.80 - 1.42) | 0.663 | |||
CC | 6 | 17 | 0.35 (0.14 - 0.90) | 0.030* | 0.35 (0.14 - 0.90) | 0.030* | |||
Dominant | TT | 281 | 279 | 1.00 | 1.00 | ||||
CT-CC | 151 | 152 | 0.99 (0.75 - 1.30) | 0.923 | 0.99 (0.75 - 1.3) | 0.922 | |||
Recessive | TT-CT | 426 | 414 | 1.00 | 1.00 | ||||
CC | 6 | 17 | 0.34 (0.13 - 0.88) | 0.026* | 0.34 (0.13 - 0.88) | 0.026* | |||
Log-additive | – | – | – | 0.91 (0.71 - 1.16) | 0.433 | 0.90 (0.71 - 1.16) | 0.432 | ||
rs928883 | Genotype | GG | 90 | 129 | 1.00 | 1.00 | 97.12% | ||
AG | 244 | 204 | 1.71 (1.24 - 2.38) | 0.001* | 1.71 (1.24 - 2.38) | 0.001* | |||
AA | 85 | 90 | 1.35 (0.91 - 2.02) | 0.138 | 1.35 (0.9 - 2.02) | 0.141 | |||
Dominant | GG | 90 | 129 | 1.00 | 1.00 | ||||
AG-AA | 329 | 294 | 1.60 (1.17 - 2.19) | 0.003* | 1.60 (1.17 - 2.19) | 0.003* | |||
Recessive | GG-AG | 334 | 333 | 1.00 | 1.00 | ||||
AA | 85 | 90 | 0.94 (0.67 - 1.31) | 0.723 | 0.94 (0.67 - 1.31) | 0.716 | |||
Log-additive | – | – | – | 1.19 (0.97 - 1.45) | 0.088 | 1.19 (0.97 - 1.45) | 0.090 |